FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry
- PMID: 34462992
- DOI: 10.1111/jon.12921
FEOBV-PET to quantify cortical cholinergic denervation in AD: Relationship to basal forebrain volumetry
Abstract
Background and purpose: Fluorine-18-fluoroethoxybenzovesamicol([18 F]-FEOBV) is a PET radiotracer previously used in neurodegenerative diseases to quantify brain cholinergic denervation. The current exploratory study aimed at verifying the reliability of such an approach in Alzheimer's disease (AD) by demonstrating its concordance with MRI volumetry of the cholinergic basal forebrain (ChBF).
Methods: The sample included 12 participants evenly divided between healthy volunteers and patients with AD. All participants underwent MRI ChBF volumetry and PET imaging with [18 F]-FEOBV. Comparisons were made between the two groups, and partial correlations were performed in the AD patients between [18 F]-FEOBV uptake in specific cortical regions of interest (ROIs) and volumetry of the corresponding ChBF subareas, which include the nucleus basalis of Meynert (Ch4), and the medial septum/vertical limb of the diagonal band of Broca (Ch1/2).
Results: Patients with AD showed both lower ChBF-Ch4 volumetric values and lower [18 F]-FEOBV cortical uptake than healthy volunteers. Volumes of the Ch4 subdivision were significantly correlated with the [18 F]-FEOBV uptake values observed in the relevant ROIs. Volumes of the Ch1/2, which remains relatively unaffected in AD, did not correlate with [18 F]-FEOBV uptake in the hippocampus, nor in any cortical area.
Conclusion: These results suggest that cortical cholinergic denervation as measured with [18 F]-FEOBV PET is proportional to ChBF atrophy measured by MRI-based volumetry, further supporting the reliability and validity of [18 F]-FEOBV PET to quantify cholinergic degeneration in AD.
Keywords: Alzheimer's disease; FEOBV; PET imaging; basal forebrain; cholinergic system; volumetry.
© 2021 American Society of Neuroimaging.
References
REFERENCES
-
- Wenzel B, Deuther-Conrad W, Scheunemann M, Brust P. Radioligand development for PET imaging of the vesicular acetylcholine transporter (VAChT) in the brain. In: Dierckx RA, Otte A, de Vries EF, van Waarde A, Lammertsma AA, editors, PET and SPECT of Neurobiological Systems. Cham: Springer; 2021, pp. 1061-90.
-
- Mulholland GK, Wieland DM, Kilbourn MR, Frey KA, Sherman PS, Carey JE, et al. [18F] fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses. Synapse 1998;30:263-74.
-
- Cyr M, Parent MJ, Mechawar N, Rosa-Neto P, Soucy J-P, Clark SD, et al. Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [18F] fluoroethoxybenzovesamicol. Behav Brain Res 2015;278:107-14.
-
- Parent M, Bedard M-A, Aliaga A, Soucy J-P, Landry St-Pierre E, Cyr M, et al. PET imaging of cholinergic deficits in rats using [18F] fluoroethoxybenzovesamicol ([18F] FEOBV). Neuroimage 2012;62:555-61.
-
- Aghourian M, Legault-Denis C, Soucy J-P, Rosa-Neto P, Gauthier S, Kostikov A, et al. Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18 F]-FEOBV. Mol Psychiatry 2017;22:1531-8.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical